Synapse Open Synapse
Biology

Bausch + Lomb swaps CEOs; Merck reveals anticipated eye drug data

BioPharma Dive · · 2 min read

Bausch and Brent Saunders “mutually agreed” on his exit from the company, according to a statement. Elsewhere, Tezspire could have a new edge on Dupixent and a recent buyout deal paid dividends.

Latest from BioPharma Dive